Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9603 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.9444 |
High Similarity |
NPD4908 |
Phase 1 |
0.9194 |
High Similarity |
NPD1610 |
Phase 2 |
0.8871 |
High Similarity |
NPD1548 |
Phase 1 |
0.8779 |
High Similarity |
NPD4625 |
Phase 3 |
0.8605 |
High Similarity |
NPD4749 |
Approved |
0.8571 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD5124 |
Phase 1 |
0.8485 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8444 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8444 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8346 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.8125 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.8125 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.8088 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8067 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.803 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8029 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7917 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7914 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.791 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7887 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7887 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7746 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7746 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7746 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7664 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7639 |
Intermediate Similarity |
NPD2796 |
Approved |
0.763 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7619 |
Intermediate Similarity |
NPD968 |
Approved |
0.7613 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7581 |
Intermediate Similarity |
NPD846 |
Approved |
0.7581 |
Intermediate Similarity |
NPD940 |
Approved |
0.758 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7157 |
Approved |
0.75 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD3225 |
Approved |
0.745 |
Intermediate Similarity |
NPD6667 |
Approved |
0.745 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7444 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7436 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7379 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7361 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7348 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD7030 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1653 |
Approved |
0.731 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.731 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7297 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD290 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7244 |
Intermediate Similarity |
NPD37 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD7095 |
Approved |
0.72 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7143 |
Intermediate Similarity |
NPD821 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7123 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7113 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7111 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7105 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7103
|
Intermediate Similarity |
NPD6233 |
Phase 2 |